More Chemistry
Bismuth-213 is the radioisotope of the element Bismuth, whose atomic nucleus has 130 neutrons in addition to the element-specific 83 protons, resulting in a mass number of 213.
The α-emitting radionuclide bismuth-213 has interesting properties as an isotope for radionuclide therapy (TRNT). Corresponding preclinical and clinical studies have already been published. The article by Stefan Ahenkorah et. al. gives an up-to-date overview [1].
See also: list of Bismuth isotopes.
Half-life T½ = 45.59(6) min (minutes) respectively 2.7354 × 103 seconds s.
Decay mode | Daughter | Probability | Decay energy | γ energy (intensity) |
---|---|---|---|---|
β- | 213Po | 97.80(10) % | 1.422(5) MeV | |
α | 209Tl | 2.20(10) % | 5.988(3) MeV |
The figure shows the radioactive decay cascade of the Bi-213 nuclide. The isotope is an unstable intermediate in the so-called neptunium series, which starts from Neptunium-237 (complete decay series: see there). p>
Direct parent isotope is: 217At.
OZ | Isotone N = 130 | Isobar A = 213 |
---|---|---|
78 | 208Pt | |
79 | 209Au | |
80 | 210Hg | 213Hg |
81 | 211Tl | 213Tl |
82 | 212Pb | 213Pb |
83 | 213Bi | 213Bi |
84 | 214Po | 213Po |
85 | 215At | 213At |
86 | 216Rn | 213Rn |
87 | 217Fr | 213Fr |
88 | 218Ra | 213Ra |
89 | 219Ac | 213Ac |
90 | 220Th | 213Th |
91 | 221Pa | 213Pa |
92 | 222U |
[1] - Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose et al.:
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
In: Pharmaceutics, (2021), DOI 10.3390/pharmaceutics13050599.
Last update: 2023-04-15
Perma link: https://www.chemlin.org/isotope/bismuth-213
© 1996 - 2024 ChemLin